TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06675032

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PCV24 formulation 1
Description: 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine formulation 1：Dosage form: Injection Specification:0.5 ml/strip Dosage: The preferred site is the anterolateral thigh (lateral femoral muscle) in infants and the deltoid muscle of the upper arm in infants and children. The preferred dosage for infants is 0.5 ml per dose.~Dosing schedule:24 months old-17 years old group: 1 dose.12-23 months old group: 2 doses, each dose at least 2 months apart.7-11 months old group: 2 doses of basic immunization, the first two doses at least 1 month apart, and a booster dose after 12 months of age.6 weeks months: 1 dose of basic immunization at each of the ages of 2, 4, and 6 months, and 1 dose of booster immunization at the age of 12-15 months, with the earliest of the first dose at the age of 6 weeks. The first dose is given at 6 weeks of age at the earliest.
Study: NCT04610580

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALXN1840
Description: ALXN1840 will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALXN1840
Description: ALXN1840 will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALXN1840
Description: ALXN1840 will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALXN1840
Description: ALXN1840 will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALXN1840
Description: ALXN1840 will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALXN1840
Description: ALXN1840 will be administered orally.
Study: NCT06675032

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PCV24 formulation 1
Description: 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine formulation 1：Dosage form: Injection Specification:0.5 ml/strip Dosage: The preferred site is the anterolateral thigh (lateral femoral muscle) in infants and the deltoid muscle of the upper arm in infants and children. The preferred dosage for infants is 0.5 ml per dose.~Dosing schedule:24 months old-17 years old group: 1 dose.12-23 months old group: 2 doses, each dose at least 2 months apart.7-11 months old group: 2 doses of basic immunization, the first two doses at least 1 month apart, and a booster dose after 12 months of age.6 weeks months: 1 dose of basic immunization at each of the ages of 2, 4, and 6 months, and 1 dose of booster immunization at the age of 12-15 months, with the earliest of the first dose at the age of 6 weeks. The first dose is given at 6 weeks of age at the earliest.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PCV24 formulation 1
Description: 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine formulation 1：Dosage form: Injection Specification:0.5 ml/strip Dosage: The preferred site is the anterolateral thigh (lateral femoral muscle) in infants and the deltoid muscle of the upper arm in infants and children. The preferred dosage for infants is 0.5 ml per dose.~Dosing schedule:24 months old-17 years old group: 1 dose.12-23 months old group: 2 doses, each dose at least 2 months apart.7-11 months old group: 2 doses of basic immunization, the first two doses at least 1 month apart, and a booster dose after 12 months of age.6 weeks months: 1 dose of basic immunization at each of the ages of 2, 4, and 6 months, and 1 dose of booster immunization at the age of 12-15 months, with the earliest of the first dose at the age of 6 weeks. The first dose is given at 6 weeks of age at the earliest.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PCV24 formulation 1
Description: 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine formulation 1：Dosage form: Injection Specification:0.5 ml/strip Dosage: The preferred site is the anterolateral thigh (lateral femoral muscle) in infants and the deltoid muscle of the upper arm in infants and children. The preferred dosage for infants is 0.5 ml per dose.~Dosing schedule:24 months old-17 years old group: 1 dose.12-23 months old group: 2 doses, each dose at least 2 months apart.7-11 months old group: 2 doses of basic immunization, the first two doses at least 1 month apart, and a booster dose after 12 months of age.6 weeks months: 1 dose of basic immunization at each of the ages of 2, 4, and 6 months, and 1 dose of booster immunization at the age of 12-15 months, with the earliest of the first dose at the age of 6 weeks. The first dose is given at 6 weeks of age at the earliest.
Study: NCT06697548

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lumbopelvic and Hip Therapeutic Exercise
Description: These motor control exercises will focus on proprioception, coordination, and sensorimotor control training and include progressive exercises that focus on transversus abdominis, lumbar multifidus, diaphragmatic, pelvic floor muscles, and deep hip stabilizers. Exercises will progress from more stabilized (e.g., pelvic tilt, cat and cow) to less stabilized and more dynamic and functional (e.g., forward bending, eccentric squat) to mimic the demands of work duty. Exercise will be trained and progressed during the clinical visits and be performed daily at home.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lumbopelvic and Hip Therapeutic Exercise
Description: These motor control exercises will focus on proprioception, coordination, and sensorimotor control training and include progressive exercises that focus on transversus abdominis, lumbar multifidus, diaphragmatic, pelvic floor muscles, and deep hip stabilizers. Exercises will progress from more stabilized (e.g., pelvic tilt, cat and cow) to less stabilized and more dynamic and functional (e.g., forward bending, eccentric squat) to mimic the demands of work duty. Exercise will be trained and progressed during the clinical visits and be performed daily at home.
Study: NCT06674239

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient Follow-up and Evaluation Form, Patient Information Form Healthy Lifestyle Behaviors Scale Education Booklet
Description: In the experimental phase of the study, an informed consent form, patient information form, healthy lifestyle behaviors scale, patient follow-up and evaluation form and education booklet were used.~Patient Information Form: This form was developed by the researchers. Healthy Lifestyle Behaviors Scale: The scale, which measures the health-promoting behaviors associated with the individual's healthy lifestyle, consists of a total of 52 items.~Patient Follow-up and Evaluation Form: Metabolic value tests are routinely requested in the institution.~Education Booklet: An education booklet was created based on the literature and the opinions of three experts.~Data collection method: Individualized education was given to the experimental group. Then, the Patient Information Form and the Healthy Lifestyle Behaviors Scale were applied as pre-test and post-test. The laboratory values of the patients were examined and recorded in the Patient Follow-up and Evaluation Form.
Study: NCT06674252

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Jiawei Bufei Tang granules
Description: Jiawei Bufei Tang is a traditional Chinese medicine formula applied by Professor Li Pingping to patients with lung cancer and qi yin deficiency syndrome. It consists of Huangqi, Codonopsis pilosula, Schisandra chinensis, Rehmannia glutinosa, Ziyuan, Mulberry bark, Snake berry, Half branch Lotus, White Hedyotis diffusa, etc. Bu Fei Tang is derived from the Yuan Dynasty's Yong Lei Ling Fang and consists of six ingredients: ginseng, astragalus, schisandra, Radix Rehmanniae, Ziyuan, and mulberry bark. It is mainly used to treat cough caused by lung qi deficiency. Jiawei Bufei Tang adds white Hedyotis diffusa, Scutellaria barbata, and snake berry to the original formula. White Hedyotis diffusa is more effective in dispelling carbuncles and detoxifying, Scutellaria barbata is more effective in dispelling phlegm and diuresis, and snake berry is more effective in dispelling scrofula and dispersing nodules, increasing the effect of clearing heat and detoxifying. This formula is particularly e

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study: NCT06673680

Intervention type: DEVICE
Intervention: Do colposcopy and cervical punch biopsy then compare between findings
Description: The aim of this study is to correlate colposcopy and histopathological findings in early screening of suspicious cervix and cervical cancer. And to do a colposcopic evaluation of all cervical lesions and the early detection of all cervical precancer and invasive lesions of the cervix in symptomatic women.
Study: NCT06675643

Intervention type: OTHER
Intervention: Non-Interventional Study
Description: Non-Interventional study
Study: NCT06675006

Intervention type: COMBINATION_PRODUCT
Intervention: Medical Massage
Description: This intervention refers to the application of therapeutic massage techniques aimed at alleviating pain and enhancing muscle relaxation in patients with nonspecific low back pain. The treatment focuses on manipulating soft tissues, including muscles, tendons, and fascia, to improve circulation, reduce muscle tension, and promote overall wellness. Medical massage is tailored to each patient's specific needs and can incorporate various techniques, including Swedish massage, Bowen Therapy, a gentle and non-invasive manual therapy, utilizes precise movements on specific points of the body to promote healing and restore balance. The therapist applies light pressure with the fingers, allowing the body to respond and relax. This technique aims to stimulate the body's innate healing mechanisms, encouraging improvements in pain levels and functional capacity. Sessions are typically structured to allow for periods of rest, giving the body time to process the treatment and enhancing its effects.
Study: NCT06675500

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Magnesium sulphate
Description: Intravenous Magnesium sulphate followed by oral tablets of Magnesium sulphate

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intravenous infusion of Normal saline 0.9 followed by starch oral tablets
Study: NCT06673485

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Patients received vitamin D and calcium supplementation during the healing period
Description: The proposed implant site and adjacent tissues were disinfected using betadine mouthwash, and standard infiltration anesthesia was administered both buccally and palatally. A paracrestal incision was then made over the intended implant location, and the mucoperiosteal flap was elevated to expose the underlying bone. Subsequently, an osteotomy was prepared using a 2.0 mm pilot drill, maintaining irrigation with sterile saline. The osseodensification protocol was employed with Densah burs in increasing diameters (2 mm, 3 mm, 4 mm) under copious irrigation. Throughout the osteotomy preparation, implant angulation was regularly checked using a paralling pin. Upon encountering haptic feedback, pressure was modulated to achieve the desired depth. The implant was then installed using a surgical handpiece, and the final insertion torque was recorded using a torque wrench, ensuring successful placement.~During the healing period, the patients recieved Vitamin D and Calcium Supplements.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Patients have not received any nutritional supplementation during the healing period.
Description: The proposed implant site and adjacent tissues were disinfected using betadine mouthwash, and standard infiltration anesthesia was administered both buccally and palatally. A paracrestal incision was then made over the intended implant location, and the mucoperiosteal flap was elevated to expose the underlying bone. Subsequently, an osteotomy was prepared using a 2.0 mm pilot drill while maintaining irrigation with sterile saline. The osseodensification protocol was employed with Densah burs in increasing diameters (2 mm, 3 mm, 4 mm) under copious irrigation. Throughout the osteotomy preparation, implant angulation was regularly checked using a paraling pin. Upon encountering haptic feedback, pressure was modulated to achieve the desired depth. The implant was then installed using a surgical handpiece, and the final insertion torque was recorded using a torque wrench, ensuring successful placement. During the healing period, the patients did not receive vitamin or calcium supplements.
Study: NCT06697548

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lumbopelvic and Hip Therapeutic Exercise
Description: These motor control exercises will focus on proprioception, coordination, and sensorimotor control training and include progressive exercises that focus on transversus abdominis, lumbar multifidus, diaphragmatic, pelvic floor muscles, and deep hip stabilizers. Exercises will progress from more stabilized (e.g., pelvic tilt, cat and cow) to less stabilized and more dynamic and functional (e.g., forward bending, eccentric squat) to mimic the demands of work duty. Exercise will be trained and progressed during the clinical visits and be performed daily at home.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extrapelvic Manual Therapy
Description: Thrust and non-thrust manual therapy will be applied to the lumbar facet, sacroiliac, and hip joints based upon the clinical exam in a semi-standardized manner
Study: NCT06689241

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enoxaparin
Description: 40mg
Study: NCT06131320

Intervention type: OTHER
Intervention: Cerebral MRI
Description: Cerebral MRI scan

Intervention type: OTHER
Intervention: Cerebral MRI
Description: Cerebral MRI scan
Study: NCT06689241

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rivaroxaban
Description: 10mg
Study: NCT06688253

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV efgartigimod
Description: IV efgartigimod
Study: NCT06697548

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extrapelvic Dry Needling
Description: Dry needling treatment to muscles of the lumbopelvic and upper thigh regions in a semi-standardized manner based upon a palpatory examination. The palpatory examination will include the erector spinae, lumbar multifidi, gluteus medius/minimus, piriformis, illiacus, and hip adductor muscles.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Deep Paced Diaphragmatic Breathing Training
Description: The breathing intervention will start with education describing the link between the diaphragm and the pelvic floor to include awareness of any breath holding patterns and finding positions that facilitate expansion of the ribs, abdominals, and pelvic floor muscles with inhalation. Then progressive training will be given to encourage deep breathing at a pace of approximately 6 breaths per minute.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Deep Paced Diaphragmatic Breathing Training
Description: The breathing intervention will start with education describing the link between the diaphragm and the pelvic floor to include awareness of any breath holding patterns and finding positions that facilitate expansion of the ribs, abdominals, and pelvic floor muscles with inhalation. Then progressive training will be given to encourage deep breathing at a pace of approximately 6 breaths per minute.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chronic Pelvic Pain Education
Description: During the first visit, participants will receive and briefly discuss the 2023 standardized patient educational handout created by the International Pelvic Pain Society with their treating provider. The educational handout describes chronic pelvic pain etiology, typical symptoms, examination, and treatments.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Chronic Pelvic Pain Education
Description: During the first visit, participants will receive and briefly discuss the 2023 standardized patient educational handout created by the International Pelvic Pain Society with their treating provider. The educational handout describes chronic pelvic pain etiology, typical symptoms, examination, and treatments.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Chronic Pelvic Pain Education
Description: During the first visit, participants will receive and briefly discuss the 2023 standardized patient educational handout created by the International Pelvic Pain Society with their treating provider. The educational handout describes chronic pelvic pain etiology, typical symptoms, examination, and treatments.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intravaginal and intrarectal pelvic floor physical therapy
Description: Superficial vulvar, perineal and intravaginal manual therapy and biofeedback utilizing commonly used techniques in previous research selected based on identified impairments from the pelvic floor examination will be performed.
Study: NCT06698237

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: immediate cold-water immersion
Description: immediate 10 minute water immersion in 10 degree Celsius
Study: NCT06688656

Intervention type: DRUG
Group type: OTHER
Intervention: Pemetrexed 500 mg/m2
Description: 1. Pemetrexed: 500mg/m² on Day 1, Q3W, administered via intravenous infusion for a total of 3 cycles.

Intervention type: DRUG
Group type: OTHER
Intervention: carboplatin
Description: AUC=5 on Day 1, Q3W，administered via intravenous infusion for a total of 3 cycles.

Intervention type: DRUG
Group type: OTHER
Intervention: Sintilimab
Description: Sintilimab, 200mg, administered via intravenous infusion on the 3rd day of each cycle, Q3W, for a total of 3 cycles.
Study: NCT05908084

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HAV
Description: HAV implantation

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: AVF
Description: AVF creation procedure
Study: NCT06632873

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 177Lu-TATE-RGD
Description: accepted intravenous injection of 177Lu-TATE-RGD
Study: NCT06686160

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plyometrics Training
Description: Patient will be given baseline treatment that includes thermotherapy+ TENS+ low intensity high repetition exercises. After we will apply our basic intervention exercise, Plyometrics are primarily used by athletes to improve performance and are used in the fitness field to a much lesser degree. This training focuses on learning to move from a muscle extension to a contraction in a explosive way, for example repeated jumping.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Theraband Resistance Exercise
Description: Patient will be given baseline treatment that includes thermotherapy+ TENS+ low intensity high repetition exercises. After we will apply our basic intervention exercise Therabands is a Set of bands which are primarily use for resistance Training for strength and Power.
Study: NCT06698237

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: delayed cold-water immersion
Description: 3 hour delayed 10 minute water immersion in 10 degree Celsius

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: immediate thermoneutral water immersion
Description: immediate 10 minute water immersion in 35 degree Celsius
Study: NCT06399484

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual mobilizations of the median nerve
Description: Slippage of the median nerve in the wrist: the subject's starting position (P0) will be recumbent supine with the cervical spine in a neutral position, the shoulder girdle in neutral position, 30º of glenohumeral abduction in neutral rotation, 90º of elbow flexion, prone-supination of the neutral forearm, wrist and fingers in neutral position. From this position the movements will be 1) Glenohumeral abduction up to 90º; 2) Glenohumeral external rotation to the frontal plane; 3) Supination of the forearm; 4) Extension of the wrist and fingers; 5) Elbow extension. This position is will combine with an ipsilateral cervical inclination (distal sliding). The proximal slide is carried out bringing the fingers of the hand towards the flexion while performing a contralateral cervical tilt.~Median nerve tension: the starting position and movements are the same described above but this time it will be done with contralateral cervical tilt.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Wrist movements
Description: Movements of the wrist joint will be performed as a placebo treatment
Study: NCT05763420

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AH Plus Bioceramic Sealer
Description: A bioactive, calcium silicate-based sealer will be used in combination with the core root canal filling material (gutta-percha). It's premixed and is dispensed in the root canal via a fine disposable syringe.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AH Plus Sealer (resin-based)
Description: A resin-based sealer will be used in combination with the core root canal material (gutta-percha). It consists of two pastes that are mixed together in equal amounts prior to application.
Study: NCT05396807

Intervention type: DEVICE
Group type: OTHER
Intervention: AI
Description: The aim of using AI software to support physicians in choosing the most effective treatment.
Study: NCT05660681

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: glycerin 0.7%/PEG 400 0.3%
Description: Eye drop with active agents from the OTC Monograph.